Quarterly ResultMay 6, 2026, 04:15 PM
agilon health Q1 Net Income $49M, Adj. EBITDA +162%; Raises FY26 Guidance
AI Summary
agilon health reported strong first-quarter 2026 financial results, with net income rising to $49 million and Adjusted EBITDA increasing by 162% to $54 million year-over-year. The company also raised its full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA, reflecting disciplined execution and progress on strategic priorities. Despite a 7% decrease in total revenue to $1.42 billion and an 11% decline in total members due to strategic market and payor exits, the company expressed confidence in its outlook. Additionally, agilon health announced the appointment of Tim O Rourke as its new CEO.
Key Highlights
- agilon health reported Q1 2026 Net Income of $49 million, up from $12 million in Q1 2025.
- Adjusted EBITDA for Q1 2026 increased 162% to $54 million from $21 million year-over-year.
- Medical Margin grew 16% to $149 million in Q1 2026, compared to $128 million in Q1 2025.
- Total revenue for Q1 2026 was $1.42 billion, a 7% decrease from $1.53 billion in Q1 2025.
- Full-year 2026 revenue guidance raised to $5.68 billion - $5.805 billion from previous $5.41 billion - $5.58 billion.
- Full-year 2026 Adjusted EBITDA guidance raised to $10 million - $40 million from previous ($15 million) - $15 million.
- Total members on the platform decreased to 536,000 as of March 31, 2026, down 11% year-over-year.
- Tim O Rourke was welcomed as the new CEO, bringing over 25 years of healthcare leadership.